Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and FOLFIRI in Metastatic Colorectal Cancer
NCT00559741Phase 2Completed
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Oct 2005
- Primary completion
- May 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Institut Cancérologique de l'Ouest. Started Oct 2005; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00559741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559741.